Safety, Tolerability and Pharmacokinetic Study of HRS-8829

Clinical trial NCT07083362 · COMPLETED

Trial details

NCT number: NCT07083362
Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Ischemia Stroke

Start date: 2025-08-06
Primary completion: 2026-01-12
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.